Fondaparinux sodium
SIGMA/SML1240 - ≥95% (HPLC)
Synonym: Fondaparin sodium; Methyl O-
CAS Number: 114870-03-0
Empirical Formula (Hill Notation): C31H43N3O49S8 · 10Na
Molecular Weight: 1728.08
Linear Formula: C31H43N3O49S8 · 10Na
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C31H53N3O49S8.10Na/c1- |
| InChI key | XEKSTYNIJLDDAZ-JASSWCPGSA |
| optical activity | [α]/D 42.0 to 55.0° (c = 0.5 in water) |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | [Na+].[Na+].[Na+].[Na+].[ |
| solubility | H2O: 20 mg/mL, clear |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | Fondaparinux sodium has been used to test its neutralizing effect towards enterovirus D68-947 infection. It may be used in ultraviolet photodissociation (UVPD) measurements. |
| Biochem/physiol Actions: | Fondaparinux sodium is an antithrombotic anticoagulant, a Factor Xa inhibitor. |
| Biochem/physiol Actions: | Fondaparinux sodium is an antithrombotic anticoagulant, a Factor Xa inhibitor. Fondaparinux sodium is chemically related to low molecular weight heparins. Its pentasaccharide structure corresponds to the antithrombin III (ATIII) binding site of heparin. Fondaparinux sodium binding at this site potentiates the natural inhibitory effect of ATIII against factor Xa by a factor of approximately 300, which results in inhibition of thrombin generation. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

